[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Announces Dividend",
    "summary": "PRINCETON, N.J., June 17, 2025--Bristol Myers Squibb Announces Dividend",
    "url": "https://finnhub.io/api/news?id=392b31b41646f3fabf00019c717a30762ed630459fb2fa4cba3e4bd4377ffce7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750191360,
      "headline": "Bristol Myers Squibb Announces Dividend",
      "id": 135340439,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, N.J., June 17, 2025--Bristol Myers Squibb Announces Dividend",
      "url": "https://finnhub.io/api/news?id=392b31b41646f3fabf00019c717a30762ed630459fb2fa4cba3e4bd4377ffce7"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors",
    "summary": "Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=aa416f6a683df9f0bb1502c6e38babd59e33d5b6b2885d21a612e8cb92b37b43",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750178340,
      "headline": "Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors",
      "id": 135358405,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=aa416f6a683df9f0bb1502c6e38babd59e33d5b6b2885d21a612e8cb92b37b43"
    }
  },
  {
    "ts": null,
    "headline": "Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly",
    "summary": "VERV jumps on Eli Lilly's buyout offer, adding next-gen gene-editing therapies to the pharma giant's pipeline.",
    "url": "https://finnhub.io/api/news?id=93eb80604315048ad74bb5486dbd182a144eafbd2e1963f10eddd4e80649ee94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750176720,
      "headline": "Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly",
      "id": 135336539,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "VERV jumps on Eli Lilly's buyout offer, adding next-gen gene-editing therapies to the pharma giant's pipeline.",
      "url": "https://finnhub.io/api/news?id=93eb80604315048ad74bb5486dbd182a144eafbd2e1963f10eddd4e80649ee94"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi",
    "summary": "PRINCETON - Bristol Myers Squibb announced the first disclosure of the primary analysis results of the marginal zone lymphoma cohort of TRANSCEND FL, an open-label, global, multicenter, Phase 2,...",
    "url": "https://finnhub.io/api/news?id=c4991deab8e4c1c07bfd663df60af649ccb97dbeac03fdff6583467428f8cb09",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750147405,
      "headline": "Bristol Myers Squibb Presents First Data from the Marginal Zone Lymphoma Cohort of the Transcend FL Trial Demonstrating Deep and Durable Responses with Breyanzi",
      "id": 135325878,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "PRINCETON - Bristol Myers Squibb announced the first disclosure of the primary analysis results of the marginal zone lymphoma cohort of TRANSCEND FL, an open-label, global, multicenter, Phase 2,...",
      "url": "https://finnhub.io/api/news?id=c4991deab8e4c1c07bfd663df60af649ccb97dbeac03fdff6583467428f8cb09"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Presents Promising Blood Cancer Drug Data at EHA Congress",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for beginners now. On June 12, Bristol Myers Squibb shared new data from its targeted protein degradation platform at the 2025 European Hematology Association/EHA Annual Congress, held in Milan from June 1 to 15. These presentations featured updated clinical findings for investigational oral […]",
    "url": "https://finnhub.io/api/news?id=66154fad584b2e361573f7d7dbec179f4892ee54aef38edb6d1c5f86cee28ad1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750141438,
      "headline": "Bristol Myers Squibb Presents Promising Blood Cancer Drug Data at EHA Congress",
      "id": 135318073,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is one of the best stocks to buy for beginners now. On June 12, Bristol Myers Squibb shared new data from its targeted protein degradation platform at the 2025 European Hematology Association/EHA Annual Congress, held in Milan from June 1 to 15. These presentations featured updated clinical findings for investigational oral […]",
      "url": "https://finnhub.io/api/news?id=66154fad584b2e361573f7d7dbec179f4892ee54aef38edb6d1c5f86cee28ad1"
    }
  }
]